Lineage Cell Therapeutics LCTX Earnings Call Transcripts

NYSE LCTX
$1.12 +0.08 (+7.69%)
As of: Nov 11, 2026 · 3:59 PM EST
7 earnings calls on file for Lineage Cell Therapeutics, from Q4 2020 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Lineage Cell Therapeutics Q2 2026 Earnings Call

Aug 6, 2026 8,819 words · 38 min read
  • Ioana HoneHead of Investor Relations
  • Brian CulleyChief Executive Officer
  • Jill HoweChief Financial Officer
  • Dr. Priyantha HerathSenior Vice President and Head of Clinical
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Lineage Cell Therapeutics Earnings Call Transcripts

Calls7
LatestAug 6, 2026
SinceQ4 2020

Fiscal 2026

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 7 Lineage Cell Therapeutics transcripts Register to get access to Lineage Cell Therapeutics’s earnings call transcripts.